Trulieve Cannabis Corp., a health care holding company based in Quincy, United States, operates within the pharmaceutical sector of the health care industry. The company is primarily engaged in the cultivation, possession, sale, and distribution of medical cannabis products. These products are specifically designed to alleviate symptoms associated with serious medical conditions, including cancer. As a holding company, Trulieve Cannabis Corp. oversees these activities through its subsidiaries.
The company is listed on the OTC Bulletin Board, a platform for trading securities that do not meet the requirements to be listed on major exchanges. As of May 28, 2026, Trulieve Cannabis Corp. had a close price of $9.288. Over the past year, the company’s stock has experienced significant fluctuations, reaching a 52-week high of $11.83 on December 17, 2025, and a 52-week low of $3.25 on June 23, 2025.
With a market capitalization of $1.78 billion, Trulieve Cannabis Corp. holds a substantial presence in the medical cannabis market. However, the company’s financial metrics indicate challenges, as evidenced by a price-to-earnings ratio of -16.03. This negative ratio suggests that the company is currently not generating profits, which is not uncommon in the early stages of growth for companies within the cannabis industry.
Trulieve Cannabis Corp. continues to focus on expanding its operations and enhancing its product offerings to better serve patients with serious medical conditions. For more information, stakeholders and interested parties can visit the company’s website at www.trulieve.com .
